Carospir
Product Images NDC 17856-0120

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carospir (NDC 17856-0120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

17856 0120 1

The label for CaroSpir (Spironolactone) oral suspension by Atlantic Biologicals Corp. It includes storage instructions, dosage of 12.5 mg/2.5 mL, and a quantity of 72 cups. The label also displays a barcode, lot number, expiration date of 11/20/20, and instructions to keep out of reach of children.*

FDA Label Image

Chemical Structure (Figure 01)

Chemical structure diagram of the active ingredient in CaroSpir, showing the steroid backbone with a methyl group and an acetylthio substitution as part of its molecular structure.*

FDA Label Image

Figure 1. Survival By Treatment Group In Rales (Figure 02)

A Kaplan-Meier survival probability plot comparing Spironolactone and Placebo groups over approximately 42 months. The y-axis shows probability, and the x-axis shows months. Spironolactone group has higher survival probability than Placebo, with sample sizes of 822 and 841 respectively. A log-rank p-value is reported as less than 0.001.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.